Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update And Entry Into Loan Facility

27 Sep 2019 07:00

RNS Number : 8763N
Tavistock Investments PLC
27 September 2019
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Ticker: TAVI

TRADING UPDATE AND ENTRY INTO LOAN FACILITY

 

27  September 2019

 

Trading update

The Board is pleased to report that the Company is trading in line with market expectations, despite challenging market conditions caused by political instability, anxieties over BREXIT outcomes and international trade disputes.

It is impossible to determine how much more challenging conditions may become over the short term and any potential impact on the Company's future trading before more normal conditions return.

The Board continues to believe that it is in the best long-term interests of the Company to improve profitability through:

·; the selective purchases of client books from retiring advisers;

·; investment in initiatives designed to significantly improve inflows of FUM; and

·; reduction of net debt through scheduled capital repayments under its existing NatWest loan facility.

The Company's regulatory capital requirement has increased as a result of these initiatives. However, the Directors' believe that seeking to raise additional capital now would be unduly dilutive for shareholders. To bolster the regulatory capital position in a manner that is not dilutive to shareholders, they have entered into an unsecured convertible loan facility (the "Facility") with two of the Company's directors and its Chief Investment Officer.

The Facility

The Facility is for £630,000 and may be drawn down by the Company at any point within the next year. The Facility is unsecured and is being provided by two of the Company's directors, Oliver Cooke and Brian Raven, and by its Chief Investment Officer, Christopher Peel. Each of them has given an irrevocable undertaking to the Company that upon receipt of 30 days' notice and subject to compliance with regulatory obligations regarding close periods, they will provide up to £210,000 of loan capital to the Company on the following terms:

·; Facility fee 5% of the funds committed;

·; interest payable on funds drawn down of 10%;

·; the repayment of any sums drawn down, together with interest thereon, to be made on 30 September 2020;

·; the option for the Company only, at its absolute discretion, to elect to convert amounts drawn down, together with interest thereon, into new ordinary shares in the Company of 1p each, at a conversion price of 2p per share, being today's bid price; and

·; a non-utilisation fee payable, if appropriate, on 30 September 2020, equivalent to 3% of funds committed but not drawn down.

Related Party Transaction

The entry into the Facility by the Company with Oliver Cooke, Brian Raven and Christopher Peel constitute transactions with related parties under the AIM Rules for Companies. The independent Non-executive Directors of the Company, Roderic Rennison and Peter Dornan, having consulted with the Company's nominated Adviser, Arden Partners, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

ENQUIRIES

Tavistock Investment plc

Oliver Cooke / Brian Raven +44 (0)1753 867000

Arden Partners plc - Nominated Adviser

Paul Shackleton +44 (0)20 7614 5900

Allenby Capital Limited - Broker

Nick Naylor / Nick Athanas +44 (0)20 3328 5656

Vested - PR Partner

Elspeth Rothwell +44 (0)20 3890 8118

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFUMFUSESU
Date   Source Headline
19th Jul 20184:52 pmRNSHolding(s) in Company
27th Jun 20187:00 amRNSResults For Year Ended 31 March 2018
16th Apr 201812:56 pmRNSDirector/PDMR Shareholding
16th Mar 20188:03 amRNSGrant of Options
5th Mar 20181:52 pmRNSReduction of Share Premium Account
13th Feb 20182:01 pmRNSDirector/PDMR Shareholding
16th Jan 201812:16 pmRNSResult of General Meeting
22nd Dec 20177:00 amRNSProposed Reduction of Share Premium Account
28th Nov 20177:00 amRNSInterim Results
26th Oct 201712:08 pmRNSCompletion of Disposal of Tavistock Financial
24th Oct 201711:33 amRNSEarly Settlement Agreement
28th Sep 201711:48 amRNSResult of AGM
5th Sep 201710:30 amRNSNotice of AGM
31st Aug 201712:48 pmRNSDirectorate Change
15th Aug 20179:36 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSDisposal of Tavistock Financial Limited
1st Aug 20178:24 amRNSResults For Year Ended 31/03/17 - Replacement
1st Aug 20177:00 amRNSResults For The Year Ended 31 March 2017
27th Jun 20177:00 amRNSTavistock Wealth Launches New Funds
12th May 20177:00 amRNSChange of Nominated Adviser
24th Apr 20177:00 amRNSSenior Appointment, Option Grant and Subscription
21st Apr 20177:00 amRNSDirector/PDMR Shareholding
13th Apr 20177:00 amRNSIssue of Options
11th Apr 20174:05 pmRNSDirector/PDMR Shareholding
6th Apr 20178:01 amRNSAppointment of Business Development Director
23rd Feb 20172:00 pmRNSIssue of Equity
22nd Feb 201710:51 amRNSResult of General Meetings
26th Jan 20171:40 pmRNSNotice of General Meetings
19th Jan 20179:41 amRNSIssue of Equity
18th Jan 201711:18 amRNSHolding(s) in Company
23rd Dec 20167:00 amRNSUnaudited Interim Accounts
28th Nov 20164:20 pmRNSFurther re Acquisition, Placing and Subscription
28th Nov 20163:36 pmRNSFurther re Acquisition, Placing and Subscription
28th Nov 20169:15 amRNSHolding(s) in Company
23rd Nov 20163:37 pmRNSResults of Placing and Subscription
23rd Nov 20167:00 amRNSProposed acquisition and fundraising
18th Oct 20167:00 amRNSHolding(s) in Company
29th Sep 20161:32 pmRNSResult of AGM
23rd Sep 201611:30 amRNSAmendment to Notice of AGM
7th Sep 20167:00 amRNSNotice of AGM and Change of Broker
25th Aug 20162:00 pmRNSIssue of Equity
5th Jul 20167:00 amRNSFinal Results
4th Jul 20167:00 amRNSIssue of Equity
22nd Jun 20162:03 pmRNSIssue of Deferred Consideration and Bonus Shares
13th Jun 20162:00 pmRNSConversion of A Ordinary Shares
10th May 20167:00 amRNSTrading Update
28th Apr 20161:00 pmRNSPayment of Deferred Consideration
14th Apr 20163:16 pmRNSIssue of Shares
21st Mar 20167:00 amRNSAcquisition, Share Subscription and Debt Facility
26th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.